Terms: = Prostate cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1
537 results:
1. Food additive emulsifiers and cancer risk: Results from the French prospective NutriNet-Santé cohort.
Sellem L; Srour B; Javaux G; Chazelas E; Chassaing B; Viennois E; Debras C; Druesne-Pecollo N; Esseddik Y; Szabo de Edelenyi F; Arnault N; Agaësse C; De Sa A; Lutchia R; Huybrechts I; Scalbert A; Pierre F; Coumoul X; Julia C; Kesse-Guyot E; Allès B; Galan P; Hercberg S; Deschasaux-Tanguy M; Touvier M
PLoS Med; 2024 Feb; 21(2):e1004338. PubMed ID: 38349899
[TBL] [Abstract] [Full Text] [Related]
2. Urinary fatty acid biomarkers for prostate cancer detection.
Noriega Landa E; Quaye GE; Su X; Badmos S; Holbrook KL; Polascik TJ; Adams ES; Deivasigamani S; Gao Q; Annabi MH; Habib A; Lee WY
PLoS One; 2024; 19(2):e0297615. PubMed ID: 38335180
[TBL] [Abstract] [Full Text] [Related]
3. Prediction models of incontinence and sexual function one year after radical prostatectomy based on data from 20 164 prostate cancer patients.
Sibert NT; Kurth T; Breidenbach C; Wesselmann S; Feick G; Carl EG; Dieng S; Albarghouth MH; Aziz A; Baltes S; Bartolf E; Bedke J; Blana A; Brock M; Conrad S; Darr C; Distler F; Drosos K; Duwe G; Gaber A; Giessing M; Harke NN; Heidenreich A; Hijazi S; Hinkel A; Kaftan BT; Kheiderov S; Knoll T; Lümmen G; Peters I; Polat B; Schrodi V; Stolzenburg JU; Varga Z; von Süßkind-Schwendi J; Zugor V; Kowalski C
PLoS One; 2023; 18(12):e0295179. PubMed ID: 38039308
[TBL] [Abstract] [Full Text] [Related]
4. Improved Outcomes with Enzalutamide in Biochemically Recurrent prostate cancer.
Freedland SJ; de Almeida Luz M; De Giorgi U; Gleave M; Gotto GT; Pieczonka CM; Haas GP; Kim CS; Ramirez-Backhaus M; Rannikko A; Tarazi J; Sridharan S; Sugg J; Tang Y; Tutrone RF; Venugopal B; Villers A; Woo HH; Zohren F; Shore ND
N Engl J Med; 2023 Oct; 389(16):1453-1465. PubMed ID: 37851874
[TBL] [Abstract] [Full Text] [Related]
5. Global Variation in Magnetic Resonance Imaging Quality of the prostate.
Giganti F; Ng A; Asif A; Chan VW; Rossiter M; Nathan A; Khetrapal P; Dickinson L; Punwani S; Brew-Graves C; Freeman A; Emberton M; Moore CM; Allen C; Kasivisvanathan V;
Radiology; 2023 Oct; 309(1):e231130. PubMed ID: 37815448
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of Ribonucleotide Reductase Induces Endoplasmic Reticulum Stress and Apoptosis, Leading to the Death of Docetaxel-resistant prostate cancer Cells.
Serttas R; Erdogan S
Anticancer Agents Med Chem; 2023; 23(17):1958-1965. PubMed ID: 37565554
[TBL] [Abstract] [Full Text] [Related]
7. TIGIT immune checkpoint blockade enhances immunity of human peripheral blood NK cells against castration-resistant prostate cancer.
Wang F; Liu S; Liu F; Xu T; Ma J; Liang J; Wang J; Liu D; Yang F; Li J; Xing N
Cancer Lett; 2023 Aug; 568():216300. PubMed ID: 37414394
[TBL] [Abstract] [Full Text] [Related]
8. A Mendelian randomization study on causal effects of 25(OH) vitamin D levels on diabetic nephropathy.
He M; Yang T; Zhou P; Bu P; Yang X; Zou Y; Zhong A
BMC Nephrol; 2023 Jun; 24(1):192. PubMed ID: 37369991
[TBL] [Abstract] [Full Text] [Related]
9. Spatial and temporal diversity of positive selection on shared haplotypes at the PSCA locus among worldwide human populations.
Iwasaki RL; Satta Y
Heredity (Edinb); 2023 Aug; 131(2):156-169. PubMed ID: 37353592
[TBL] [Abstract] [Full Text] [Related]
10. Dietary Quality and Circulating Lipidomic Profiles in 2 Cohorts of Middle-Aged and Older Male Finnish Smokers and American Populations.
Zhang T; Naudin S; Hong HG; Albanes D; Männistö S; Weinstein SJ; Moore SC; Stolzenberg-Solomon RZ
J Nutr; 2023 Aug; 153(8):2389-2400. PubMed ID: 37328109
[TBL] [Abstract] [Full Text] [Related]
11. Inter-reader agreement of the prostate imaging quality (PI-QUAL) score for basic readers in prostate MRI: A multi-center study.
Basar Y; Alis D; Seker ME; Kartal MS; Guroz B; Arslan A; Sirolu S; Kurtcan S; Denizoglu N; Karaarslan E
Eur J Radiol; 2023 Aug; 165():110923. PubMed ID: 37320883
[TBL] [Abstract] [Full Text] [Related]
12. Physicochemical and Biopharmaceutical Controllability of New Self-Assembled Fatty Acid Conjugated Leuprolide for the Enhanced Anticancer Activity.
Ngo HV; Bak HE; Nguyen HD; Lee KW; Park C; Lee BJ
Int J Nanomedicine; 2023; 18():2325-2344. PubMed ID: 37168738
[TBL] [Abstract] [Full Text] [Related]
13. The Prevalence of prostate cancer Among Young Men Below 55 Years of Age in Nigeria.
Ntekim A; Folasire A; Odukoya OA
Cancer Control; 2023; 30():10732748231175255. PubMed ID: 37130758
[TBL] [Abstract] [Full Text] [Related]
14. LBA02-09 EMBARK: A Phase 3 Randomized Study of Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in High-risk Biochemically Recurrent prostate cancer.
J Urol; 2023 Jul; 210(1):224-226. PubMed ID: 37119051
[TBL] [Abstract] [Full Text] [Related]
15. C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis.
Zhou K; Li C; Chen T; Zhang X; Ma B
Front Endocrinol (Lausanne); 2023; 14():1111277. PubMed ID: 36817592
[TBL] [Abstract] [Full Text] [Related]
16. Foreign accent syndrome as a heralding manifestation of transformation to small cell neuroendocrine prostate cancer.
Broderick A; Labriola MK; Shore N; Armstrong AJ
BMJ Case Rep; 2023 Jan; 16(1):. PubMed ID: 36717160
[TBL] [Abstract] [Full Text] [Related]
17. Effect of early pelvic floor muscle exercises (Kegel's) after Robotic prostatectomy in prostate cancer patients.
Chitre A; Kulkarni JN
J Robot Surg; 2023 Jun; 17(3):1065-1070. PubMed ID: 36564680
[TBL] [Abstract] [Full Text] [Related]
18.
Gorish BMT
Cancer Control; 2022; 29():10732748221140785. PubMed ID: 36377557
[TBL] [Abstract] [Full Text] [Related]
19. Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic prostate cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.
Ma TM; Sun Y; Malone S; Roach M; Dearnaley D; Pisansky TM; Feng FY; Sandler HM; Efstathiou JA; Syndikus I; Hall EC; Tree AC; Sydes MR; Cruickshank C; Roy S; Bolla M; Maingon P; De Reijke T; Nabid A; Carrier N; Souhami L; Zapatero A; Guerrero A; Alvarez A; Gonzalez San-Segundo C; Maldonado X; Romero T; Steinberg ML; Valle LF; Rettig MB; Nickols NG; Shoag JE; Reiter RE; Zaorsky NG; Jia AY; Garcia JA; Spratt DE; Kishan AU;
J Clin Oncol; 2023 Feb; 41(4):881-892. PubMed ID: 36269935
[TBL] [Abstract] [Full Text] [Related]
20. Radiotherapy activity in the COVID 19 pandemic: Brazil's operational national-level study.
Moraes FY; Gouveia AG; Lima RP; Bratti VF; Hamamura AC; Viani GA
J Cancer Policy; 2023 Jun; 36():100367. PubMed ID: 36216270
[TBL] [Abstract] [Full Text] [Related]
[Next]
